Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancer

Autor: Naoyuki Uehata, Keita Kouzu, Hironori Tsujimoto, Hidekazu Sugasawa, Kotaro Wakamatsu, Yoji Kishi, Hideki Ueno

Publikováno v: Surgical Case Reports, Vol 7, Iss 1, Pp 1-6 (2021)

Abstract Background The prognosis of recurrent and unresectable gastric cancer remains poor despite the development of multidisciplinary treatments. Ramucirumab (RAM) has been proven effective against unresectable or recurrent gastric cancer. However

Externí odkaz: https://doaj.org/article/711f3df557364a6f90227584b91e1ada

Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancer.

Autor: Uehata N; Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan., Kouzu K; Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan., Tsujimoto H; Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan. tsujihi@ndmc.ac.jp., Sugasawa H; Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan., Wakamatsu K; Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan., Kishi Y; Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan., Ueno H; Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Publikováno v: Surgical case reports [Surg Case Rep] 2021 Apr 20; Vol. 7 (1), pp. 97. Date of Electronic Publication: 2021 Apr 20.